Results 41 to 50 of about 39,687 (208)

Metabolism of ticagrelor in patients with acute coronary syndromes. [PDF]

open access: yes, 2018
© The Author(s) 2018Ticagrelor is a state-of-the-art antiplatelet agent used for the treatment of patients with acute coronary syndromes (ACS). Unlike remaining oral P2Y12 receptor inhibitors ticagrelor does not require metabolic activation to exert its ...
B Ibanez   +41 more
core   +2 more sources

TULBURĂRILE HEMOSTAZEI LA PACIENȚII CU NSTEMI ȘI MARKERII DE DIAGNOSTIC

open access: yesBuletinul Academiei de Ştiinţe a Moldovei: Ştiinţe Medicale, 2022
Background. Hemostasis disorder is an important mechanism of cardiovascular disease, and its pathogenetic contribution to the evolution of NSTEMI is particularly notable in the context of the significance of the pathophysiological pattern caused by ...
DANILA Tatiana   +4 more
doaj   +1 more source

Outcome of very elderly (octogenarians) patients with coronary artery disease, all diagnosed by coronary angiography [PDF]

open access: yes, 2017
Background: Women with ischemic heart disease (IHD) typically present less severe coronary artery atherosclerosis. Despite that, as compared with men, women maintain a worse outcome.
Arrivi, Alessio   +8 more
core   +1 more source

Managing NSTEMI in older patients [PDF]

open access: yesThe Lancet, 2021
Versaci, Francesco   +2 more
openaire   +4 more sources

Multiple Myeloma Presenting with Nstemi [PDF]

open access: yesIndian Journal of Cardiovascular Disease in Women WINCARS, 2016
AbstractMultiple myeloma, also known as plasma cell myeloma, is a cancer of plasma cells, a type of white blood cell normally responsible for producing antibodies. Multiple myeloma is associated with hyperviscosity of the blood depending on the properties of the para-protein.
M. kiran, A. Praveen
openaire   +1 more source

COMPARISON OF INTRACORONARY VERAPAMIL VS ADENOSINE FOR RESTORATION OF CORONARY BLOOD FLOW POST PERCUTANEOUS CORONARY INTERVENTION (PCI) IN PATIENTS WITH NO-REFLOW

open access: yesPakistan Armed Forces Medical Journal, 2020
Objective: To determine the efficacy of intracoronary verapamil vs adenosine in restoration of coronary blood flow, post PCI in patients with No-Reflow. Study Design: Double blind (patient/operator blind) randomized control trial.
Mohsin Saif   +8 more
doaj   +1 more source

Access and non–access site bleeding after percutaneous coronary intervention and risk of subsequent mortality and major adverse cardiovascular events:Systematic review and meta-analysis [PDF]

open access: yes, 2015
Background: The prognostic impact of site-specific major bleeding complications after percutaneous coronary intervention (PCI) has yielded conflicting data.
Buchan, Iain   +10 more
core   +1 more source

Pregnancy-associated myocardial infarction following elective caesarean section for two previous caesarean sections and myomectomy

open access: yesJournal of Family Medicine and Primary Care, 2020
A 39-year-old woman, gravida 4, para 2 + 1 (2 alive) for elective second repeat caesarean delivery on account of two previous caesarean sections and one open myomectomy.
Adaeze Chidinma Oreh   +3 more
doaj   +1 more source

Fractional flow reserve-guided management in stable coronary disease and acute myocardial infarction: recent developments [PDF]

open access: yes, 2015
Coronary artery disease (CAD) is a leading global cause of morbidity and mortality, and improvements in the diagnosis and treatment of CAD can reduce the health and economic burden of this condition.
Berry, Colin   +5 more
core   +1 more source

TICAGRELOR PHARMACOKINETICS IN NSTEMI

open access: yesJournal of the American College of Cardiology, 2016
We aimed to compare the ticagrelor uptake between NSTEMI patients and a control group with stable coronary artery disease. Observational, prospective, single-center study ([NCT02292277][1]) including 28 patients with NSTEMI and 17 controls undergoing elective percutaneous coronary intervention ...
Manne Holm   +2 more
openaire   +1 more source

Home - About - Disclaimer - Privacy